Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Assets (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Return on Assets for 3 consecutive years, with 0.84% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 32.0% to 0.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.84% through Dec 2025, down 32.0% year-over-year, with the annual reading at 0.68% for FY2025, 8.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.84% at Mereo BioPharma, down from 0.72% in the prior quarter.
  • The five-year high for Return on Assets was 0.1% in Q3 2023, with the low at 0.84% in Q4 2025.
  • Average Return on Assets over 3 years is 0.53%, with a median of 0.51% recorded in 2024.
  • The sharpest move saw Return on Assets plummeted -41bps in 2024, then fell -20bps in 2025.
  • Over 3 years, Return on Assets stood at 0.26% in 2023, then plummeted by -103bps to 0.52% in 2024, then tumbled by -61bps to 0.84% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.84%, 0.72%, and 0.76% for Q4 2025, Q3 2025, and Q2 2025 respectively.